Opis projektu
Rozwój narzędzi do walki z lekoopornymi patogenami
Antybiotykooporność stanowi jeden z głównych problemów współczesnej medycyny. Choć antybiotyki uratowały niezliczoną liczbę ludzkich istnień, coraz to nowe oporne na nie patogeny zagrażają dobrostanowi przyszłych pokoleń. Tworzy to potrzebę podjęcia stanowczych kroków w celu złagodzenia wpływu drobnoustrojów na systemy opieki zdrowotnej na całym świecie. W ramach finansowanego przez UE projektu REVERSE powstanie strategia zapobiegania rozwojowi lekoopornych patogenów i zarządzania nimi. Obierając multidyscyplinarne podejście, naukowcy poszerzą istniejące zasoby wiedzy dotyczące lekoopornych patogenów, w ten sposób przyczyniając się do rozwoju nowych strategii ograniczających wpływ drobnoustrojów na zdrowie obywateli i europejską gospodarkę.
Cel
Emerging antibiotic resistance has become an endemic problem, slowly increasing under the radar and depriving future generations of effective therapies. The goal of REVERSE is to develop and implement cost-effective strategies and tools for the prevention and clinical management of healthcare-associated infections due to multidrug-resistant pathogens, and to reduce the burden of antimicrobial resistance in high prevalence healthcare settings. To achieve these goals, REVERSE will use a mixed-methods approach combining quantitative research with implementation science and economic analysis. The aim is to produce results that go beyond the evidence-base we have today. REVERSE will answer the question about real-life effectiveness of infection prevention and control programmes in combination with antibiotic stewardship on healthcare-associated infections due to multidrug-resistant microorganisms. It will offer implementation strategies to the participating hospitals but also study the effectiveness of external implementation support in a hybrid implementation-effectiveness trial. REVERSE will develop a novel health-economic framework that allows for incorporating of effect of changes in the use of a range of antibiotics on antibiotic resistant infections, and estimating long-term population effects, to integrate both into cost-effectiveness analyses. It will be able to conclude on effectiveness and applicability of prevention strategies in lower-resource settings by cross-checking its programmes with activities in low-and-middle income countries. Four European countries will have a platform of highly experienced hospitals to build on and expand a national network for combatting antibiotic resistance. REVERSE will produce tools and bundles on infection prevention and control, antibiotic stewardship and implementation support. Massive online open courses and other dissemination strategies will make the findings of REVERSE accessible to a wide range of stakeholders.
Dziedzina nauki
- engineering and technologyelectrical engineering, electronic engineering, information engineeringinformation engineeringtelecommunicationsradio technologyradar
- medical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugsantibiotics
- medical and health sciencesbasic medicinepharmacology and pharmacydrug resistancemultidrug resistance
- natural sciencesbiological sciencesmicrobiology
- medical and health sciencesbasic medicinepharmacology and pharmacydrug resistanceantibiotic resistance
Słowa kluczowe
Program(-y)
Zaproszenie do składania wniosków
Zobacz inne projekty w ramach tego zaproszeniaSzczegółowe działanie
H2020-SC1-2020-Single-Stage-RTD
System finansowania
RIA - Research and Innovation actionKoordynator
8006 Zurich
Szwajcaria